Application of the Lugano classification for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the ProLog consensus …

…, L Schwartz, G Goldmacher, R Jarecha… - Journal of Nuclear …, 2023 - Soc Nuclear Med
Our objective was to provide consensus recommendations from a consortium of academic
and industry experts in the field of lymphoma and imaging for consistent application of the …

Application of the Lugano classification for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the PRoLoG consensus …

…, L Schwartz, G Goldmacher, R Jarecha… - Journal of Nuclear …, 2023 - Soc Nuclear Med
The aim of this initiative was to provide consensus recommendations from a consortium of
academic and industry experts in the field of lymphoma and imaging for the consistent …

Algorithm variability in the estimation of lung nodule volume from phantom CT scans: results of the QIBA 3A public challenge

…, L Zhang, E Vega, M Bloom, R Jarecha… - Academic radiology, 2016 - Elsevier
Rationale and Objectives Quantifying changes in lung tumor volume is important for diagnosis,
therapy planning, and evaluation of response to therapy. The aim of this study was to …

Inter-method performance study of tumor volumetry assessment on computed tomography test-retest data

…, H Beaumont, L Hadjiiski, R Jarecha… - Academic radiology, 2015 - Elsevier
Rationale and objectives Tumor volume change has potential as a biomarker for diagnosis,
therapy planning, and treatment response. Precision was evaluated and compared among …

Evaluation of simulated lesions as surrogates to clinical lesions for thoracic CT volumetry: the results of an international challenge

…, NA Obuchowski, A Buckler, M Athelogou, R Jarecha… - Academic radiology, 2019 - Elsevier
Rationale and Objectives To evaluate a new approach to establish compliance of
segmentation tools with the computed tomography volumetry profile of the Quantitative Imaging …

Importance of volumetric measurement processes in oncology imaging trials for screening and evaluation of tumors as per response evaluation criteria in solid tumors

RC Vemuri, R Jarecha, KK Hwi… - Asian Pacific Journal …, 2014 - koreascience.kr
Cancer, like any disease, is a pathologic biological process. Drugs are designed to interfere
with the pathologic process and should therefore also be validated using a functional …

To determine correlation of inter reader variability in sum of diameters using RECIST 1.1 with end point assessment in lung cancer.

…, S Bajpai, J Narang, M O'Connor, R Jarecha - 2021 - ascopubs.org
e13557 Background: Lung cancer is the leading cause of cancer death in the world including
more than 160,000 deaths in the US. The purpose of the study was to determine whether …

[HTML][HTML] Mantle Cell Lymphoma: Incidence of gastrointestinal involvement and correlation with overall response-retrospective review of multiple multicenter trials

S Bajpai, J Narang, S Narang, R Mankala, RR Jarecha… - Blood, 2020 - Elsevier
Background:Mantle cell lymphoma (MCL) is a rare kind of Non-Hodgkin Lymphoma. The
incidence of Gastrointestinal (GI) involvement is an important factor in assessing patients and …

Comparison of response using mRECIST versus RECIST 1.1 Criteria in advanced hepatocellular carcinoma: A retrospective analysis of multicenter clinical trials.

J Narang, S Bajpai, R Jarecha, M Sharma, O Bohnsack - 2020 - ascopubs.org
4595 Background: mRECIST 2010 criteria for Hepatocellular Carcinoma (HCC) response
assessment were focused on a concept of measuring viable tumor tissue showing …

Retrospective comparison of Cheson 2007 and Lugano classification criteria in independent review assessment of FDG-avid lymphomas.

J Narang, S Bajpai, R Jarecha, S Karve, K Ludajic… - 2019 - ascopubs.org
e19015 Background: Revised Response Criteria in Malignant Lymphoma (Cheson 2007)
and Lugano Classification are the most commonly used guidelines to assess response to …